| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0024-3205(03)00195-4 |
| P698 | PubMed publication ID | 12697270 |
| P2093 | author name string | Yukio Ikeda | |
| Kozo Hashimoto | |||
| Tadashi Suehiro | |||
| Yoshitaka Kumon | |||
| Koji Nishiya | |||
| Noriyasu Tanimoto | |||
| Susumu Ohkubo | |||
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| Human serum paraoxonase | Q28279519 | ||
| Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics | Q28300402 | ||
| Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis | Q28592044 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| The mortality of rheumatoid arthritis | Q34338843 | ||
| Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures | Q35768215 | ||
| Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase | Q39802300 | ||
| Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins | Q41066989 | ||
| Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor. | Q43586928 | ||
| A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response | Q50148311 | ||
| The molecular basis of the human serum paraoxonase activity polymorphism. | Q52542904 | ||
| Proinflammatory Cytokines But Not Acute Phase Serum Amyloid A Or C-Reactive Protein, Downregulate Paraoxonase 1 (Pon1) Expression By Hepg2 Cells | Q58304388 | ||
| Paraoxonase gene polymorphism in Japanese subjects with coronary heart disease | Q71876568 | ||
| Reduction of Acute-Phase Proteins with Tenidap Sodium, a Cytokine-Modulating Anti-Rheumatic Drug | Q72083048 | ||
| Influence of serum amyloid A protein on high-density lipoprotein in chronic inflammatory disease | Q72285195 | ||
| Serum arylesterase/diazoxonase activity and genetic polymorphisms in patients with type 2 diabetes | Q73226465 | ||
| Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response | Q77124527 | ||
| Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R | Q77380948 | ||
| Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants | Q77416567 | ||
| Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation | Q78171097 | ||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 2877-2885 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Life Sciences | Q5256275 |
| P1476 | title | Serum paraoxonase activity decreases in rheumatoid arthritis | |
| P478 | volume | 72 |
| Q34586496 | Anti-cyclic citrullinated peptide antibodies and paraoxonase-1 polymorphism in rheumatoid arthritis |
| Q35541874 | Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis. |
| Q36253671 | Atherosclerosis and rheumatoid arthritis: more than a simple association |
| Q88917533 | Cardiovascular Safety of Biologics and JAK Inhibitors in Patients with Rheumatoid Arthritis |
| Q38813397 | Cardiovascular risk in patients with rheumatoid arthritis |
| Q47142883 | Correlation of PON1 polymorphisms with ankylosing spondylitis susceptibility: A case-control study in Chinese Han population |
| Q57476499 | Correlation of Paraoxonase-1 with the Severity of Crohn's Disease |
| Q36829246 | Effects of orange juice and hesperetin on serum paraoxonase activity and lipid profile in hyperuricemic rats |
| Q46958759 | Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis |
| Q33684694 | Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients |
| Q24647387 | Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis |
| Q42450626 | Human paraoxonase-1 gene expression by HepG2 cells is downregulated by interleukin-1β and tumor necrosis factor-α, but is upregulated by interleukin-6 |
| Q35638659 | Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis |
| Q46566663 | Oxidative stress in chronic otitis media. |
| Q46521932 | Oxidative stress in otosclerosis. |
| Q27006749 | Paired measurements of paraoxonase 1 and serum amyloid A as useful disease markers |
| Q83208416 | Paraoxonase and arylesterase levels in rheumatoid arthritis |
| Q38236740 | Rheumatoid arthritis and metabolic syndrome |
| Q42097527 | SELDI-TOF mass spectrometry of High-Density Lipoprotein |
| Q42616955 | Sequence identification, chromosomal mapping and tissue specific expression of the porcine paraoxonase 1 (PON1) gene |
| Q36497033 | Serum arylesterase and paraoxonase activity in patients with chronic hepatitis |
| Q44957832 | The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis |
| Q36576648 | The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation |
| Q48422098 | Time-dependent modulation of rat serum paraoxonase 1 activity by fasting |
Search more.